
1. Reumatol Clin (Engl Ed). 2021 Nov;17(9):556-557. doi:
10.1016/j.reumae.2020.03.005.

Why choose cyclosporin A as first-line therapy in COVID-19 pneumonia.

Sanchez-Pernaute O(1), Romero-Bueno FI(2), Selva-O'Callaghan A(3).

Author information: 
(1)Rheumatology Division, Jiménez Díaz Foundation University Hospital and Health 
Research Institute, Universidad Autónoma de Madrid, Madrid, Spain. Electronic
address: osanchez@fjd.es.
(2)Rheumatology Division, Jiménez Díaz Foundation University Hospital and Health 
Research Institute, Universidad Autónoma de Madrid, Madrid, Spain.
(3)Department of Internal Medicine, Hospital Universitari Val d'Hebron,
Universitat Autonoma de Barcelona, Barcelona, Spain.

Dataset described in
    Lancet. 2020 Mar 28;395(10229):1033-1034.

DOI: 10.1016/j.reumae.2020.03.005 
PMCID: PMC8555974
PMID: 34756322  [Indexed for MEDLINE]

